Acute pancreatitis attributed to the use of interferon alfa-2b

Gastroenterology

Volumn 119, Issue 1, 2000, Pages 230-233

  Eland, Ingo A ^a   Rasch, Marijke C ^b   Sturkenboom, Miriam J C M ^a   Bekkering, Frank C ^a   Brouwer, Johannes T ^a   Delwaide, Jean ^c   Belaiche, Jacques ^c   Houbiers, Ghislain ^d   Stricker, Bruno H Ch ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d Hospital Bois de l'Abbaye   (Belgium)

^e Inspectorate for Health Care ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON;

ACUTE PANCREATITIS; ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG SAFETY; HEPATITIS NON A NON B; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL;

EID: 0034235806     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.8528     Document Type: Article

References (23)

1. Dorr RT. Interferon-alpha in malignant and viral diseases. A Review. Drugs 1993;45:177-211.
2. Gutterman JU. Cytokine therapeutics: Lessons from interferon alpha. Proc Natl Acad Sci U S A 1994;91:1198-1205.
3. Tilg H. New insights into the mechanisms of interferon alfa: An immunoregulatory and anti-inflammatory cytokine. Gastroenterology 1997;112:1017-1021.
4. Borden EC, Parkinson D. A perspective on the clinical effectiveness and tolerance of interferon-alpha. Semin Oncol 1998;25:3-8.
5. Nesher G, Ruchlemer R. Alpha-interferon-induced arthritis: Clinical presentation treatment, and prevention. Semin Arthritis Rheum 1998;27:360-365.
6. Koh LK, Greenspan FS, Yeo PP. Interferon-alpha induced thyroid dysfunction: Three clinical presentations and a review of the literature. Thyroid 1997;7:891-896.
7. Sata M, Yano Y, Yoshiyama Y, Ide T, Kumashiro R, Suzuki H, Tanikawa K. Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B. J Gastroenterol 1997;32: 206-210.
8. Wolf Y, Haddad R, Jossipov J, Werbin N. Alpha-interferon induced severe pneumonitis. J Toxicol Clin Toxicol 1997;35:113-114.
9. Chambers RB, Downie A, Foote B, Davidorf FH. Interferon alfa-associated retinopathy. J Am Osteopath Assoc 1997;97:43-45.
10. Higashi Y, Sakai K, Tada S, Miyase S, Nakamura T, Kamio T, Haraguchi O. Case report: Agranulocytosis induced by interferon-alpha therapy for chronic hepatitis C. J Gastroenterol Hepatol 1996;11:1012-1015.
11. Phillips TM. Interferon-alpha induces renal dysfunction and injury. Curr Opin Nephrol Hypertens 1996;5:380-383.
12. Greenfield SM, Harvey RS, Thompson RP. Rhabdomyolysis after treatment with interferon alfa. BMJ 1994;309:512.
13. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198-1210.
14. Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992;326:589-593.
15. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Saf 1996;14:406-423.
16. Sotomatsu M, Shimoda M, Ogawa C, Morikawa A. Acute pancreatitis associated with interferon-alpha therapy for chronic myelogenous leukemia. Am J Hematol 1995;48:211-212.
17. Sevenet F, Sevenet C, Capron D, Descombes P. Pancreatite aigue et interferon. Gastroenterol Clin Biol 1999;23:1256.
18. Kovacs JA, Bechtel C, Davey RT, Jr., Falloon J, Polis MA, Walker RE, Metcalf JA, Davey V, Piscitelli SC, Baseler M, Dewar R, Salzman NP, Masur H, Lane HC. Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: Results of a phase I/II trial. J Infect Dis 1996;173:840-848.
19. Shearer WT, Kline MW, Abramson SL, Fenton T, Starr SE, Douglas SD. Recombinant human gamma interferon in human immunodeficiency virus-infected children: Safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211). Clin Diagn Lab Immunol 1999;6:311-315.
20. Stadler WM, Vogelzang NJ, Vokes EE, Charette J, Whitman G. Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: A phase II study in metastatic renal-cell cancer. Cancer Chemother Pharmacol 1992;31:213-216.
21. Ono Y, Kimura T, Nakano I, Furukawa M, Ito T, Sakamoto S, Konomik, Nawata H. Acute pancreatitis induced by hypercalcaemia associated with adult T-cell leukaemia: A case report. J Gastroenterol Hepatol 1996;11:193-195.
22. Shinohara E, Yamashita S, Kihara S, Hirano K, Ishigami M, Arai T, Nozaki S, Kameda-Takemura K, Kawata S, Matsuzawa Y. Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C. Hepatology 1997;25:1502-1506.
23. Yamagishi S, Abe T, Sawada T. Human recombinant interferon alpha-2a (r IFN alpha-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient. Am J Gastroenterol 1994;89:2280.